Rheumatology International

, Volume 33, Issue 5, pp 1283–1288 | Cite as

Association of TLR4 gene non-missense single nucleotide polymorphisms with rheumatoid arthritis in Chinese Han population

  • Hongju Yang
  • Chuanyu Wei
  • Qin Li
  • Tao Shou
  • Yan Yang
  • Chunjie Xiao
  • Min Yu
  • Ming Li
  • Zhili Yang
  • Jieying Zhang
  • Bingrong Zheng
Original Article


Toll-like receptor4 (TLR4) plays an important role in the induction and regulation of the innate or adaptive immune responses. Thus, the genetic variation in TLR4 gene may influence the development of autoimmune diseases such as rheumatoid arthritis (RA). Several studies have investigated the roles of genetic polymorphisms of TLR4 gene in RA, but most of these studies were restricted to two cosegregating functional missense polymorphisms Asp299Gly and Thr399Ile. To determine whether non-missense genetic polymorphisms located in regulatory region of TLR4 are related to RA in a Chinese Han population, four single nucleotide polymorphisms (SNPs) situated on 3′ untranslating region (UTR) and 5′ UTR were genotyped in 213 RA patients and 247 unrelated ethnically matched controls using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and direct sequencing techniques. Significant genetic associations were observed with the 3′ UTR SNP rs41426344 and rs7873784. The minor allele C and homozygotic variant genotype CC of rs41426344 and minor allele C of rs7873784 were identified to be risk factors for the development of RA in Chinese Han people. Furthermore, by comparing the variation allele frequencies to other populations, prevalent genetic ethnic specificity was observed in all the four SNPs. Our study suggested that the effect of non-missense polymorphisms located in regulatory region would not be neglected in disease association analysis.


Toll-like receptor4 (TLR4) 3′ Untranslating region (UTR) and 5′ UTR single nucleotide polymorphisms (SNPs) Rheumatoid arthritis (RA) Chinese Han people 



This study was supported by Key Project of Applied Basic Research Program of Yunnan Province (Grant No. 2011FA004), Yunnan Province Young Scientist Project (Grant No. 2009CI044), Yunnan University Key Teacher Project (Grant No. 21132014), Natural Science Foundation of Yunnan University (2010YB005).


  1. 1.
    Lawrence JS, Heberden Oration (1970) 1969: rheumatoid arthritis: nature or nurture? Ann Rheum Dis 29:357–379Google Scholar
  2. 2.
    Orozco G, Rueda B, Martin J (2006) Genetic basis of rheumatoid arthritis. Biomed Pharmacother 60:656–662PubMedCrossRefGoogle Scholar
  3. 3.
    Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI (1989) HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA classII region. Proc Natl Acad Sci 86:10049–10053PubMedCrossRefGoogle Scholar
  4. 4.
    Deighton CM, Walker DJ, Griffiths ID, Roberts DF (1989) The contribution of HLA to rheumatoid arthritis. Clin Genet 36:178–182PubMedCrossRefGoogle Scholar
  5. 5.
    Medzhitov R, Preston-Hurlburt P Jr, Janeway CA (1997) A human homologous of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394–397PubMedCrossRefGoogle Scholar
  6. 6.
    Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteinslinking innate and acquired immunity. Nat Immunol 2:675–680PubMedCrossRefGoogle Scholar
  7. 7.
    Poltorak A, He X, Smirnova I et al (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085–2088PubMedCrossRefGoogle Scholar
  8. 8.
    Hoshino K, Takeuchi O, Kawai T et al (1999) Toll-like receptor 4 (TLR4)—deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749–3752PubMedGoogle Scholar
  9. 9.
    Ohashi K, Burkart V, Flohe S, Kolb H (2000) Cutting edge: heatshock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164:558–561PubMedGoogle Scholar
  10. 10.
    Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T et al (2002) Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor4. J Exp Med 195:99–111PubMedCrossRefGoogle Scholar
  11. 11.
    Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J et al (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276:10229–10233PubMedCrossRefGoogle Scholar
  12. 12.
    Radstake TR, Franke B, Hanssen S, Netea MG, Welsing P, Barrera P et al (2004) The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum 50:999–1001PubMedCrossRefGoogle Scholar
  13. 13.
    Kilding R, Akil M, Till S, Amos R, Winfield J, Iles MM et al (2003) A biologically important single nucleotide polymorphism within the toll-like receptor-4 gene is not associated with rheumatoid arthritis. Clin Exp Rheumatol 21:340–342PubMedGoogle Scholar
  14. 14.
    Sanchez E, Orozco G, Lopez-Nevot MA, Jimenez-Alonso J, Martin J (2004) Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 63:54–57PubMedCrossRefGoogle Scholar
  15. 15.
    Sheedy FJ, Marinou I, O’Neill LAJ, Wilson AG (2008) The Mal/TIRAP S180L and TLR4 G299D polymorphisms are not associated with susceptibility to or severity of rheumatoid arthritis. Ann Rheum Dis 67:1328–1331PubMedCrossRefGoogle Scholar
  16. 16.
    Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M et al (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187–191PubMedCrossRefGoogle Scholar
  17. 17.
    Erridge C, Stewart J, Poxton IR (2003) Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor4 gene show no deficit in lipopolysaccharide signalling. J Exp Med 197:1787–1791PubMedCrossRefGoogle Scholar
  18. 18.
    Brand S, Staudinger T, Schnitzler F et al (2005) The role of toll-like receptor4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn’s disease. Inflamm Bowel Dis 7:645–652CrossRefGoogle Scholar
  19. 19.
    Zheng BR, Li Q, Wei CY, Qin J, Shou T, Zhou RY, Shao JR, Yang Y, Xiao CJ (2010) Lack of association of TLR4 gene Asp299Gly and Thr399Ile polymorphisms with rheumatoid arthritis in Chinese Han population of Yunnan Province. Rheumatol Int 30:1249–1252PubMedCrossRefGoogle Scholar
  20. 20.
    Cheng I, Plummer SJ, Casey G, Wittel JS (2007) Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev 16:352–355PubMedCrossRefGoogle Scholar
  21. 21.
    Simhan HN, MacPhenson T, Caritis SN, Krohn MA (2008) Maternal and fetal Toll-like receptor 4 genotype and chorionic plate inflammatory lesions. Am J Obstet Gynecol 199:400.e1–400.e4CrossRefGoogle Scholar
  22. 22.
    Hishida A, Matsuo K, Goto Y et al (2009) Toll-like receptor 4 +3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese. Helicobacter 14:47–53PubMedCrossRefGoogle Scholar
  23. 23.
    Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ (2005) Sequence variants of toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 65:11771–11778PubMedCrossRefGoogle Scholar
  24. 24.
    Duan ZX, Zhu PF, Dong H, Gu W, Yang C, Liu Q et al (2007) Functional significance of the TLR4/11367 polymorphism identified in Chinese Han population. Shock 28:160–164PubMedCrossRefGoogle Scholar
  25. 25.
    Kloz M, Baumert J, Muller M, Khuseyinova N, Klopp N, Thorand B et al (2008) Association between variations in the TLR4 gene and incident type 2 diabetes is modified by the ratio of total cholesterol to HDL-cholesterol. BMC Med Genet. doi: 10.1186/1471-2350-9-9 Google Scholar
  26. 26.
    Banus S, Bottema RW, Siezen CL, Vandebriel RJ, Reimerink J, Mommers M et al (2007) Toll-like receptor 4 polymorphism associated with the response to whole-cell pertussis vaccination in children from the KOALA study. Clin Vaccine Immunol 14:1377–1380PubMedCrossRefGoogle Scholar
  27. 27.
    Xu J, Lowey J, Wiklund F, Sun J, Lindmark F, Hsu FC et al (2005) The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk. Cancer Epidemiol Biomarkers Prev 14:2563–2568PubMedCrossRefGoogle Scholar
  28. 28.
    Wang MH, Helzlsouer KJ, Smith MW, Hoffman-Bolton JA, Clipp SL, Grinberg V et al (2009) Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate 69:874–885PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Hongju Yang
    • 1
  • Chuanyu Wei
    • 2
  • Qin Li
    • 3
  • Tao Shou
    • 3
  • Yan Yang
    • 3
  • Chunjie Xiao
    • 1
  • Min Yu
    • 1
  • Ming Li
    • 1
  • Zhili Yang
    • 1
  • Jieying Zhang
    • 1
  • Bingrong Zheng
    • 1
  1. 1.Key Laboratory of Bioresources Conservation and Utilization and Human Genetics Center of Yunnan UniversityKunmingPeople’s Republic of China
  2. 2.Yan’an Affiliated Hospital of Kunming Medical CollegeKunmingPeople’s Republic of China
  3. 3.Kunhua Affiliated Hospital of Kunming Medical CollegeKunmingPeople’s Republic of China

Personalised recommendations